Role of Metabolites in Diagnosing Chronic and Infectious Diseases and the Efficacy of Therapeutic Interventions

These scenarios share an urgent need to develop noninvasive low-cost technologies that can help to make important decisions affecting health, quality of life, cost, and public health policy It is. Recently, I am interested in understanding the role of metabolites in the diagnosis of chronic and infectious diseases and the effects of therapeutic intervention. Since metabolites represent the current state of biochemical processes in the body, they are often more relevant than genomic and proteomic data in understanding the current state of disease and appropriate intervention.

Case-control studies are applicable to assess chronic diseases, infectious diseases and injuries, and population-based interventions (Friis & Sellers, 2004). In this study, Jenkins et al. (2008) estimated the field effect of monovalent and trivalent oral poliovirus vaccines in Nigeria; this is an assessment of population-based intervention, Jenkins et al. (2010) reported vaccine-derived gray matter I studied. Influenza virus infection study in Nigeria. Data collection methods for case-control studies include standard interviews or questionnaires, hospital records, industrial records, health insurance forms, and demographics records. In order to collect data, it is usually necessary to personally interact with participants via e-mail or telephone (developed countries). (Friis & Sellers, 2004)

However, on a global scale, the numbers may be more crude and less reliable. Roughly speaking, people in developing countries often die of different causes than infancy, ie infectious diseases and chronic diseases. By definition, chronic illness usually entails evidence on patient records over the years. There, infectious diseases may soon be separated from hospitals and doctors. In countries where doctors are scarce, it is often necessary to tackle to deal with specific causes of death. For example, the estimation in remote areas of Africa and Asia is more preliminary.

Some diseases can be infectious and chronic, for example long-term infectious skin diseases or diseases such as currently incurable HIV. In addition, there may be a common mechanism of underlying infection and chronic diseases, for example damage may cause infection or chronic back problems. Other factors such as the strength of the immune response of humans, the state of vaccination, the resilience and mental state, or the current state of health can affect human diseases. Due to genetic, biological, environmental or socioeconomic features, several populations or age groups have different susceptibility to specific diseases. Therefore, certain diseases may not occur to everyone, or may have the same severity. In addition, people can successfully manage many chronic diseases with the help of changes in lifestyle, drugs and other forms of assistance.